Improving Clinical Outcomes and Quality of Life with Massage Therapy in Youth and Young Adults with Cystic Fibrosis: a Pilot Study.
cystic fibrosis
massage therapy
musculoskeletal pain
pulmonary function
quality of life
Journal
International journal of therapeutic massage & bodywork
ISSN: 1916-257X
Titre abrégé: Int J Ther Massage Bodywork
Pays: United States
ID NLM: 101539415
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
12
3
2019
pubmed:
12
3
2019
medline:
12
3
2019
Statut:
epublish
Résumé
Cystic Fibrosis (CF) is an autosomal recessive disorder of exocrine glands characterized by abnormal production of thick mucus, primarily in bronchi of the lungs. Individuals experience recurrent respiratory infections, increased work of breathing, cough and musculoskeletal changes with pain. Previous research found that massage therapy (MT) decreased pain, muscle tightness, and anxiety in individuals with CF, but did not use valid/reliable measurements of quality of life (QOL). To evaluate the effects of MT on QOL and clinical outcomes in individuals 8 to 21 years old with CF. A 622-bed nonprofit pediatric hospital in Ohio in the United States. Convenience sample of 24 patients with CF; 12 randomly assigned to treatment and control groups, respectively. Prospective two-group controlled pre/post pilot study using deep tissue myofascial trigger point massage over 10 to 12 weeks. Pediatric Quality of Life Inventory (Peds QL 4.0); Cystic Fibrosis Questionnaire-Revised (CFQ-R); numeric rating scales (NRS) for pain, muscle tightness, ease of breathing, relaxation; pulmonary function (PFT); single breath count; thoracic excursion (TE). All participants were Caucasian; mean age 15.7 (SD = 3.5) years; 16 (66.6%) female. No significant differences were found in terms of age, gender, baseline pain between MT and control groups. At the final visit, compared to the control group, the children in MT group showed statistically significantly reduced muscle tightness ( Massage therapy was found to significantly reduce muscle tightness, marginally significantly help pain, relaxation, and thoracic excursion in participants with CF.
Sections du résumé
BACKGROUND
BACKGROUND
Cystic Fibrosis (CF) is an autosomal recessive disorder of exocrine glands characterized by abnormal production of thick mucus, primarily in bronchi of the lungs. Individuals experience recurrent respiratory infections, increased work of breathing, cough and musculoskeletal changes with pain. Previous research found that massage therapy (MT) decreased pain, muscle tightness, and anxiety in individuals with CF, but did not use valid/reliable measurements of quality of life (QOL).
PURPOSE
OBJECTIVE
To evaluate the effects of MT on QOL and clinical outcomes in individuals 8 to 21 years old with CF.
SETTING
METHODS
A 622-bed nonprofit pediatric hospital in Ohio in the United States.
PARTICIPANTS
METHODS
Convenience sample of 24 patients with CF; 12 randomly assigned to treatment and control groups, respectively.
RESEARCH DESIGN AND INTERVENTION
UNASSIGNED
Prospective two-group controlled pre/post pilot study using deep tissue myofascial trigger point massage over 10 to 12 weeks.
MEASUREMENTS
METHODS
Pediatric Quality of Life Inventory (Peds QL 4.0); Cystic Fibrosis Questionnaire-Revised (CFQ-R); numeric rating scales (NRS) for pain, muscle tightness, ease of breathing, relaxation; pulmonary function (PFT); single breath count; thoracic excursion (TE).
RESULTS
RESULTS
All participants were Caucasian; mean age 15.7 (SD = 3.5) years; 16 (66.6%) female. No significant differences were found in terms of age, gender, baseline pain between MT and control groups. At the final visit, compared to the control group, the children in MT group showed statistically significantly reduced muscle tightness (
CONCLUSIONS
CONCLUSIONS
Massage therapy was found to significantly reduce muscle tightness, marginally significantly help pain, relaxation, and thoracic excursion in participants with CF.
Types de publication
Journal Article
Langues
eng
Pagination
4-15Déclaration de conflit d'intérêts
CONFLICT OF INTEREST NOTIFICATION The authors declare there are no known conflicts of interest associated with this study.
Références
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117
J Pediatr Psychol. 1999 Apr;24(2):175-81
pubmed: 10361400
Med Care. 2001 Aug;39(8):800-12
pubmed: 11468499
Pediatr Pulmonol. 2002 Dec;34(6):473-7
pubmed: 12422345
J Pediatr Psychol. 2003 Dec;28(8):535-45
pubmed: 14602844
Ambul Pediatr. 2003 Nov-Dec;3(6):329-41
pubmed: 14616041
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Pediatr Pulmonol. 2005 Oct;40(4):330-5
pubmed: 16106349
Chest. 2005 Oct;128(4):2347-54
pubmed: 16236893
Clin J Pain. 2006 Jul-Aug;22(6):532-7
pubmed: 16788339
J Am Osteopath Assoc. 2007 May;107(5):191-6
pubmed: 17596587
Paediatr Respir Rev. 2008 Sep;9(3):220-32
pubmed: 18694714
J Cyst Fibros. 2009 Jan;8(1):79-81
pubmed: 18718820
Pain. 2009 Jun;143(3):223-7
pubmed: 19359097
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
J Pediatr. 1998 Feb;132(2):255-9
pubmed: 9506637
J Pediatr. 1998 May;132(5):854-8
pubmed: 9602199